Il-yang Pharm. Co., Ltd

Industry-academic Cooperation Foundation, Sookmyung Women's University

Samsung Life Public Welfare Foundation

Hyundai Motor Company

Kia Motors Corporation

Korea Institute of Science and Technology

Samsung Life Welfare Foundation

Mediplex Corporation, Korea

Sang Yoon Kim

Jeong Min Park

Dae Ho Cho

Sa Ik Bang

Sun Young Yoon

Ha Rum Lee

Yoo Rim Park

Juah Son

Jeong Seon Min

Ick Chan Kwon

Jin Young Lee

Seung Beom Park

Youngro Byun

In San Kim

Deok Ki Kim

Kwang Meyung Kim

Ju Hee Ryu

Min Keun Kwon

Won Jang Jeong

Rang-Woon Park

Ok-cheol Jeon

Min Kyung Jung

E Sak Lee

Hyun Soo Ju

Hae Kyoung Lim

Hee Jong Kim

Soo Gyeong Ha

Eun Sung Jun

Si Nae Lee

The present invention relates to a peptide promoting angiogenesis and novel use thereof. More particularly, the invention relates to peptides promoting angiogenesis, and the use of the peptide for promoting angiogenesis and preventing or treating angiogenesis-related disease. The peptide of the present invention have an excellent effect on promoting angiogenesis. Accordingly, it is useful for preventing or treating angiogenesis-related disease and for preparing regeneration of skin flap, wound and burn healing, implantation of artificial skin and preparation of blood vessels for transplantation.

Peptides for promoting angiogenesis and use thereof

Disclosed is a drug-fluorophore complex for specific detection of tumor cells. Specifically, the drug-fluorophore complex includes a tumor cell-targeting drug penetrating tumor cells and non-tumor cells at different rates or levels, and a fluorescent substance chemically bonded to the tumor cell-targeting drug. The drug-fluorophore complex enables specific imaging of tumor cells only with high accuracy in a very simple manner without causing cytotoxicity.

Drug-fluorophore complex for specific detection of tumor cells

A shift lever assembly and assembling method for an automatic transmission vehicle may include a shift lever housing including divided components to be assembled, a shift lever, when assembled, one end of which is disposed in the divided components and connected pivotably to one or more of the divided components and the other end of which is arranged to protrude outside through a range hole formed in one of the divided components, and a plurality of elastic pins that are fitted cooperatively into the divided components when assembled to connect integrally the divided components.

Shift lever assembly for automatic transmission vehicle and assembling method thereof

The present invention relates to novel peptides and use thereof and more specifically is directed to a peptide with anti-inflammatory effect, a polynucleotide encoding the peptide, a pharmaceutical composition comprising the peptide or polynucleotide for preventing or treating inflammatory diseases, an anti-inflammatory drug, an over-the-counter (OTC) drug composition comprising the peptide for preventing or ameliorating inflammation, a health food composition for alleviating or ameliorating inflammation, a cosmetic composition for preventing or ameliorating inflammation, a method for treating inflammatory diseases, comprising administrating the pharmaceutical composition to the subject suspected of having inflammatory disease, a method for preparing a mimetic of the peptide and a method for designing the same.

Peptides and use thereof

The present invention relates to a peptide promoting angiogenesis and novel use thereof. More particularly, the invention relates to peptides promoting angiogenesis, and the use of the peptide for promoting angiogenesis and preventing or treating angiogenesis-related disease. The peptide of the present invention have an excellent effect on promoting angiogenesis. Accordingly, it is useful for preventing or treating angiogenesis-related disease and for preparing regeneration of skin flap, wound and burn healing, implantation of artificial-skin and preparation of blood vessels for transplantation.

Peptides for promoting angiogenesis and an use thereof

Heparin conjugates and methods of making and use thereof are disclosed. An illustrative heparin conjugate includes a composition wherein a bile acid is bonded to heparin through the 3-carbon of the bile acid. A spacer may be interposed between the bile acid and the heparin. Another embodiment includes a targeting moiety bonded to the heparin-bile acid conjugate through a spacer. Another illustrative heparin conjugate includes heparin covalently bonded to a sulfonated moiety, such as a naphthalene trisulfonate residue. A method of treating cancer includes administering a heparin conjugate to an individual in need thereof.

Heparin conjugates and methods

Growing community of inventors

Seoul, South Korea

Sang Yoon Kim